Mark Rus, Group Vice President of Neuroscience of Shire Pharmaceuticals, has led teams across multiple therapeutic areas over the past 12 years in the US, Europe, Canada, and other countries around the world. Because of his proven results, accomplishments, and strategic success in the industry, Mark was recently nominated by Pharmaceutical Executive Magazine in 2017 as one of the top 11 Emerging Leaders in the life sciences.
For more information about Mark, please visit his personal website.
